Pharmaceuticals
-
Trials target care for critically ill Covid-19 patients
Two UK universities have embarked on a major clinical trial to study alternatives to ventilator care for patients critically ill with Covid-19. Read more
-
Backing for remdesivir and other breaking virus news
The anti-Ebola drug remdesivir is "highly effective" at halting the action of SARS-Cov-2 virus, according to new laboratory research. Read more
-
MERS research points to Covid-19 vaccine
A new study is suggesting that an existing vaccine delivery approach could have potential against Covid-19. Read more
-
Plasma therapy shows promise – China
Plasma therapy from recovered patients has shown promise as a treatment for critically ill Covid-19 victims, Chinese doctors have reported. Read more
-
Promising’ COVID-19 vaccine revealed
A potential vaccine for COVID-19 has been described for the first time after promising mice studies, US scientists have revealed today (2 April 2020). Read more
-
SARS drug ready for clinical trial
A drug developed to treat lung disease has shown early promise against the Covid-19 virus, researchers reported last night. Read more
-
Treatment hope for babies with high-grade glioma
Targeted drugs could be used to treat some infants with high-grade glioma, according to the biggest study to date on the aggressive brain tumour. Read more
-
Heart drugs ‘safe’ in Covid 19 patients
Researchers have examined the impact of common antihypertensive drugs on patients with Covid 19. Read more
-
Analysis points to drugs to aid Covid-19 care
There is no evidence contraindicating NSAIDs for the care of patients with Covid-19 infection, according to UK researchers. Read more
-
Millions pour into Covid-19 research
The UK poured £10 million into key Covid-19 research projects yesterday, backing the search for a vaccine and ready-to-use drugs. Read more
